RBC Q2 Earnings Confirm Strength But Don't Alter Execution-Dependent Thesis

What happened

Royal Bank of Canada reported strong Q2 2026 results with 25% EPS growth and high-teens ROE, driven by 20%+ net income growth in Wealth and Capital Markets while domestic banking benefited from easier year-over-year provisioning comparisons. Impaired loans continued to rise, though forward-looking credit metrics hint at stabilization, keeping asset quality in a manageable but watchful zone. The results underscore RBC's diversified franchise power, but the stock's 41% rally over the past year means these earnings are largely priced in at ~16x P/E and ~2.4x P/B. The core investment debate remains about flawless execution on the HSBC Canada integration, City National remediation, and AI deployment—not about the underlying earnings quality. Until there is clear evidence of progress on those swing factors, the strong quarter does not justify adding to positions.

Implication

The Q2 beat shows RBC's diversified model is firing on all cylinders—domestic banking is stabilizing, market-facing units are in a Goldilocks environment, and capital markets are thriving. However, the thesis is now fully about flawless execution on HSBC Canada cost synergies, City National OCC remediation, and AI model risk, with no margin for error. The stock at 16x P/E and 2.4x P/B after a massive run leaves limited upside unless these execution milestones are met ahead of schedule. Investors should wait for evidence of sustainable progress on these fronts—such as visible cost saves from HSBC, an OCC consent order lift, or AI-driven credit improvements—before adding or initiating positions. The earnings report does not change the risk/reward calculus; it reaffirms the quality but not the timing.

Thesis delta

The Q2 results are better than expected and show that the market-facing segments can deliver strong growth even as credit cycles turn, but they do not alter the fundamental uncertainty around the three key swing factors. The thesis shifts from 'value recovery' to 'execution verification'—the stock now trades at a premium that assumes perfect execution, so any stumble will be punished disproportionately. Therefore, the WAIT judgment remains appropriate; the upside from earnings strength is already discounted.